Four new β chain hemoglobin variants without clinical or hematological effects: Hb San Bruno [β39(C5)Gln→His]; Hb Fort Dodge [β93(F9)Cys→Tyr]; Hb Rhode Island [β116(G18)His→Tyr]; and Hb Inglewood [β142(H20)Ala→Thr]

James D. Hoyer, Daniel J. McCormick, Karen Snow, Kathleen S. Kubik, Michael W. Holmes, D. Brian Dawson, Ruth Shaber, Mark Marner, Jennifer Hosmer, Nancy Shinno, Virgil F. Fairbanks

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Four new β chain hemoglobin variants without clinical or hematological effects: Hb San Bruno [β39(C5)Gln→His]; Hb Fort Dodge [β93(F9)Cys→Tyr]; Hb Rhode Island [β116(G18)His→Tyr]; and Hb Inglewood [β142(H20)Ala→Thr]'. Together they form a unique fingerprint.